CABANA Trial: The Aftermath after the Negative / Neutral Results
Keywords:
atrial fibrillation, catheter ablation, pulmonary vein isolation, antiarrhythmic drug therapyAbstract
The results of the CABANA trial were recently presented at the Heart Rhythm Society Meeting in May 2018, indicating that ablation in patients with atrial fibrillation (AF) did not confer a benefit over drug treatment in the intention-to treat analysis, but did so in an on-treatment analysis. The presentation stirred commotion in the medical community with fierce controversy appearing in the media, mostly related to an apparent willingness of electrophysiologists to dispel the first and accept the second type of analysis. Rhythmos 2018;13(3): 45-47.Downloads
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
